Stay informed with the latest litigation news. Explore now
Explore the details of the Apotex Inc. V. Boehringer Ingelheim Pharmaceuticals, Inc. case under case number 1:24-cv-00577 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.
The following parties are involved in this case, with their respective legal representatives for the case.
| Name | Represented By |
|---|---|
| Apotex Inc. | - |
| Boehringer Ingelheim Pharma GmbH & Co. KG | - |
Patents not found - set an alert to get notified when patents are added.
The Docket Entries section provides a chronological list of all significant filings and court actions in this case.
| Date | Docket Entry | Type |
|---|---|---|
Set alerts for critical docket entry | ||
| Nov 5, 2024 | STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to December 11, 2024 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/05/2024) | PACER Document |
| Dec 10, 2024 | STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to January 15, 2025 - filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Tigan, Jeremy) (Entered: 12/10/2024) | PACER Document |
| Jan 14, 2025 | STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to January 31, 2025 - filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Tigan, Jeremy) (Entered: 01/14/2025) | PACER Document |
| Jan 30, 2025 | STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 7, 2025 - filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Tigan, Jeremy) (Entered: 01/30/2025) | PACER Document |
| Feb 5, 2025 | STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to the Complaint to February 28, 2025 - filed by Apotex Inc.. (Haney, Megan) (Entered: 02/05/2025) | PACER Document |
| Feb 28, 2025 | PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/28/2025) | PACER Document |
| Feb 28, 2025 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/28/2025) | PACER Document |
| Feb 28, 2025 | CONSENT DECREE AND FINAL JUDGMENT. Signed by Judge Maryellen Noreika on 2/28/2025. ***Civil Case Terminated*** (dlw) (Entered: 02/28/2025) | PACER Document |
| Sep 10, 2024 | SO ORDERED re 15 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to October 17, 2024 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 10/17/2024; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 10/17/2024; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 10/17/2024). ORDERED by Judge Maryellen Noreika on 9/10/2024. (dlw) | PACER Document |
| Oct 15, 2024 | SO ORDERED re 16 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to November 7, 2024 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 11/7/2024; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 11/7/2024; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 11/7/2024). ORDERED by Judge Maryellen Noreika on 10/15/2024. (dlw) | PACER Document |
| Nov 5, 2024 | SO ORDERED re 17 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to December 11, (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 12/11/2024; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 12/11/2024; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 12/11/2024). ORDERED by Judge Maryellen Noreika on 11/5/2024. (dlw) | PACER Document |
| Dec 10, 2024 | SO ORDERED re 18 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to January 15, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 1/15/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 1/15/2025; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 1/15/2025). ORDERED by Judge Maryellen Noreika on 12/10/2024. (dlw) | PACER Document |
| Jan 14, 2025 | SO ORDERED re 19 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to January 31, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 1/31/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 1/31/2025; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 1/31/2025). ORDERED by Judge Maryellen Noreika on 1/14/2025. (dlw) | PACER Document |
| Jan 31, 2025 | SO ORDERED re 20 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 7, (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 2/7/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 2/7/2025; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 2/7/2025). ORDERED by Judge Maryellen Noreika on 1/31/2025. (dlw) | PACER Document |
| Feb 5, 2025 | SO ORDERED re 21 STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to the Complaint to February 28, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 2/28/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 2/28/2025; Boehringer Ingelheim Pharmaceuticals, Inc. answer due 2/28/2025). ORDERED by Judge Maryellen Noreika on 2/5/2025. (dlw) | PACER Document |